Selvita S.A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Selvita S.A..The latest application filed is for "pyridone derivatives and their use as kinase inhibitors".

Company Profile

2.9.13

Selvita S.A. - Cracow N/A PL
SELVITA S.A. - Krakow PL
SELVITA S.A. - Kralow PL
SELVITA SA - Krakow N/A PL
SELVITA S.A. - BOBRZYNSKIEGO 14 KRAKOW PL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases Grant 10,577,365 - Dreas , et al.	2020-03-03
Benzimidazole derivatives as kinase inhibitors Grant 10,174,013 - Czardybon , et al. J	2019-01-08
Pyridone Derivatives And Their Use As Kinase Inhibitors App 20180305331 - RZYMSKI; Tomasz ; et al.	2018-10-25
Pyrazolidine Derivatives And Related Compounds App 20180265467 - GALEZOWSKI; Michal ; et al.	2018-09-20
Derivatives Of Quinoline As Inhibitors Of Dyrk1a And/or Dyrk1b Kinases App 20180179199 - Dreas; Agnieszka ; et al.	2018-06-28
Substituted Quinoxaline Derivatives App 20180148429 - Fabritius; Charles-Henry Robert Yves ; et al.	2018-05-31
Substituted Quinoxaline Derivatives App 20180118718 - Fabritius; Charles-Henry Robert Yves ; et al.	2018-05-03
Substituted tricyclic benzimidazoles as kinase inhibitors Grant 9,745,299 - Rzymski , et al. August 29, 2	2017-08-29
Novel Benzimidazole Derivatives As Kinase Inhibitors App 20170152249 - CZARDYBON; Wojciech ; et al.	2017-06-01
Benzimidazole derivatives as Kinase Inhibitors Grant 9,388,192 - Czardybon , et al. July 12, 2	2016-07-12
Pyridine Derivatives As 5-ht6 Receptor Antagonists App 20160009697 - FABRITIUS; Charles-Henry ; et al.	2016-01-14
Novel Benzimidazole Derivatives as Kinase Inhibitors App 20150336967 - CZARDYBON; Wojciech ; et al.	2015-11-26
Substituted Tricyclic Benzimidazoles As Kinase Inhibitors App 20150274726 - Rzymski; Tomasz ; et al.	2015-10-01
Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent Grant 8,604,217 - Brzozka , et al. December 10, 2	2013-12-10
Compound, A Process For Its Preparation, A Pharmaceutical Composition, Use Of A Compound, A Method For Modulating Or Regulating Serine/threonine Kinases And A Serine/threonine Kinases Modulating Agent App 20120184535 - BRZOZKA; Krzysztof ; et al.	2012-07-19
Derivatives Of Tetrabromobenzimidazole, A Process For The Preparation Thereof, A Pharmaceutical Composition Comprising The Same, A Method Of Using The Same, A Method For Modulating Or Regulating Serine/threonine Kinases, And Serine/threonine Kinases Modulating Agent App 20110230481 - Brzozka; Krzysztof ; et al.	2011-09-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.